首页> 美国卫生研究院文献>other >Post-exposure Prophylaxis after Hepatitis C Occupational Exposure in the Interferon-free Era
【2h】

Post-exposure Prophylaxis after Hepatitis C Occupational Exposure in the Interferon-free Era

机译:无干扰素时代丙型肝炎职业接触后的接触后预防

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose of reviewHealthcare personnel are at risk for occupational exposures to bloodborne pathogens. Primary prevention remains the first line of defense, but secondary prevention measures known to be effective should be implemented when percutaneous exposures occur. Hepatitis C virus (HCV) is a major infectious cause of liver-related morbidity and mortality. Chronic HCV treatment has changed dramatically, with many all-oral directly acting anti-HCV antiviral (DAA) regimens now available. Evidence for the use of DAAs as post-exposure prophylaxis (PEP) after occupational exposures to HCV is summarized here.
机译:审查目的医护人员有职业性接触血源性病原体的风险。一级预防仍然是第一道防线,但是当发生经皮暴露时,应采取已知有效的二级预防措施。丙型肝炎病毒(HCV)是肝脏相关发病率和死亡率的主要感染原因。慢性HCV治疗已发生了巨大变化,现在有许多全口服直接作用的抗HCV抗病毒(DAA)方案。在此总结了在职业性接触HCV后将DAA用作暴露后预防(PEP)的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号